Posted by Michael Wonder on 25 Aug 2025
Injectable form of Ocrevus for relapsing remitting multiple sclerosis recommended for PBS listing
22 August 2025 - This new form of ocrelizumab is given as an injection under the skin (subcutaneously), takes a much shorter time and can be delivered by a local health care professional, making it more convenient.
The PBAC recommended that a new form of ocrelizumab (Ocrevus) for treating people with relapsing remitting multiple sclerosis be listed on the PBS following its July 2025 meeting.
